Articles

Results 1 to 5 of 13


The challenge in obtaining broad antibody genus claims in the US

USA - May 29 2018 Functionally defined genus claims are vulnerable to invalidity based on lack of written description support, particularly where it is difficult to…

Sale of a drug under confidentiality is not considered invalidating secret use under US post AIA

Australia, USA - March 16 2016 For US patent applications filed post introduction of the America Invents Act (AIA) (which changed from first-to-invent to first-to-file), sale and…

Induced infringement of patents - changes to US law

USA - October 21 2012 In the United States, two possible types of indirect infringement are known, (i) induced infringement and (ii) contributory infringement. 

Australian High Court rule on obviousness - the Rosuvastatin (CRESTOR) decision

Australia - September 3 2015 The High Court on 2 September 2015 handed down its decision in the appeal by AstraZeneca against a finding of the Full Federal Court that the claims…

Can two vials unite to create a patent term extension right?

Australia - May 15 2020 In 2016 the Productivity Commission’s “Intellectual Property Arrangements - Inquiry Report” recommended to the Australian Federal Government that…

Paul Whenman